SevenBridge Financial Group’s Alaunos Therapeutics TCRT Stock Holding History

SevenBridge Financial Group’s Portfolio TCRT Stock Details TCRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-67	Closed	-$707	–	206
2023 Q4	$707	Sell	67 -66	-50%	-$795	﹤0.01%	191
2023 Q3	$2.64K	Hold	133	–	–	﹤0.01%	184
2023 Q2	$10.2K	Hold	133	–	–	﹤0.01%	174
2023 Q1	$12.6K	Hold	133	–	–	﹤0.01%	174
2022 Q4	$13K	Hold	133	–	–	﹤0.01%	174
2022 Q3	$34K	Buy	+133	New	+$38.6K	0.01%	166
2018 Q4	–	Sell	-1	Closed	-$1K	–	603
2018 Q3	$1K	Hold	1	–	–	﹤0.01%	576
2018 Q2	$1K	Hold	1	–	–	﹤0.01%	587
2018 Q1	$1K	Hold	1	–	–	﹤0.01%	599
2017 Q4	$1K	Hold	1	–	–	﹤0.01%	611
2017 Q3	$1K	Hold	1	–	–	﹤0.01%	598
2017 Q2	$1K	Hold	1	–	–	﹤0.01%	628
2017 Q1	$1K	Hold	1	–	–	﹤0.01%	614
2016 Q4	$1K	Hold	1	–	–	﹤0.01%	625
2016 Q3	$1K	Hold	1	–	–	﹤0.01%	605
2016 Q2	$1K	Buy	+1	New	+$1.09K	﹤0.01%	726

Other funds holding TCRT

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ACM

Allred Capital Management Dallas, Texas $275M AUM 18.19% 1-Year Est. Return

SevenBridge Financial Group's TCRT Position: Q1 2024 in Review

SevenBridge Financial Group sold out of Alaunos Therapeutics (TCRT) in Q1 2024, closing a stake of 67 shares — an estimated $707 sold.

SevenBridge Financial Group first reported a position in TCRT in Q2 2016 and held it in 16 quarters. The position peaked at $34K in Q3 2022. 45 funds tracked by Wall St. Rank hold TCRT as of Q1 2024.

SevenBridge Financial Group reported no remaining Alaunos Therapeutics position as of Q1 2024 after selling out during the quarter.
SevenBridge Financial Group sold 67 Alaunos Therapeutics shares in Q1 2024, an estimated $707.
SevenBridge Financial Group first reported a position in Alaunos Therapeutics in Q2 2016 and held it in 16 quarters.
SevenBridge Financial Group's Alaunos Therapeutics position peaked at $34K in Q3 2022.
45 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q1 2024.

Based on SevenBridge Financial Group's 13F filing for Q1 2024, filed 10 May 2024.